Companies: 49,246 Total Market Cap: 132441797263938.02

Embla Medical hf.

CPH-EMBLA
Healthcare Medical Devices
Rank #5945
Market Cap 2.03 B
Volume 31,121
Price 4.75
Change (%) 1.61%
Country or region Iceland Iceland

Embla Medical hf.'s latest marketcap:

2.03 B

As of 05/20/2025, Embla Medical hf.'s market capitalization has reached $2.03 B. According to our data, Embla Medical hf. is the 5945th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 2.03 B
Revenue (ttm) 892.95 M
Net Income (ttm) 75.13 M
Shares Out 426.36 M
EPS (ttm) 0.18
Forward PE 24.31
Ex-Dividend Date n/a
Earnings Date 04/29/2025
Market Cap Chart
Data Updated: 05/20/2025

Embla Medical hf.'s yearly market capitalization.

Embla Medical hf. has seen its market value drop from kr20.44 B to kr13.43 B since 2020, representing a total decrease of 34.31% and an annual compound decline rate (CAGR) of 9.13%.
Date Market Cap Change (%)
05/20/2025 kr13.43 B -13.03%
12/30/2024 kr15.20 B 31.74%
12/29/2023 kr11.54 B -18.15%
12/30/2022 kr14.10 B -21.07%
12/30/2021 kr17.86 B -12.64%
12/30/2020 kr20.44 B

Company Profile

About Embla Medical hf.

Embla Medical hf., along with its subsidiaries, specializes in non-invasive orthopedic products, serving markets across Europe, the Middle East, Africa, the Americas, and the Asia-Pacific.

Business Segments

  • Prosthetics and Neuro Orthotics: Offers mechanical and bionic products, including microprocessor-controlled feet, knees, hands, fingers, and neuro orthotic joints for lower and upper limb support.
  • Bracing and Supports: Provides spinal, hip, knee, foot, ankle, and hand support devices, along with injury recovery solutions for fractures, post-operative care, and ligament injuries.
  • Patient Care: Delivers prosthetics for limb loss or difference and orthotics for neurological, gait, and musculoskeletal conditions.

Customer Base

The company serves specialized healthcare providers, including orthopedic and prosthetic clinics, hospitals, and surgery centers.

Distribution

Embla Medical hf. sells its products through a direct sales network and distributors.

Corporate Background

Originally founded in 1971 as Össur hf., the company rebranded as Embla Medical hf. in April 2024. Headquartered in Reykjavik, Iceland, it operates as a subsidiary of William Demant Invest A/S.

Frequently Asked Questions

As of 05/20/2025, Embla Medical hf. (including the parent company, if applicable) has an estimated market capitalization of $2.03 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

Embla Medical hf. global market capitalization ranking is approximately 5945 as of 05/20/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region Iceland
Founded 1971
IPO Date n/a
Employees 4,061
CEO Sveinn Solvason
Sector Healthcare
Industry Medical Devices
Address Grjótháls 5
Reykjavik
Iceland
Website https://www.emblamedical.com